Latest News about RHHBY
Recent news which mentions RHHBY
From Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
From InvestorPlace
From Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
April 15, 2022
From Benzinga
From Benzinga
Volume Springs Back Into The OTC Markets In March – Take A Look At Some Of The Top Movers
April 14, 2022
From Benzinga
Read Why Pliant Therapeutics Shares Are Soaring Today
April 13, 2022
From Benzinga
From Benzinga
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
From Benzinga
From InvestorPlace
From Benzinga
Genentech's Ocrevus Shows Benefit In Disability Progression & Cognitive Decline In Multiple Sclerosis
April 04, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
March 25, 2022
From Benzinga
Why Are ImmunoGen Shares Trading Lower Today
March 21, 2022
From Benzinga
Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population
March 16, 2022
From Benzinga
2 Top Stocks to Buy in March and Hold Forever
March 15, 2022
From Motley Fool
The OTCQX's Top 10 Experience A Shuffle In February
March 15, 2022
From Benzinga
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
Viatris Just Snagged a Major FDA Approval
March 03, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.